Stryker Corp (SYK): Ronda E Stryker , director of Stryker Corp sold 12,000 shares on May 5, 2016. The Insider selling transaction was reported by the company on May 6, 2016 to the Securities and Exchange Commission. The shares were sold at $109.40 per share for a total value of $1,312,750.25 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 4, 2016, Ronda E Stryker (director) sold 12,000 shares at $109.01 per share price.On Apr 29, 2016, Glenn S Boehnlein (VP, Chief Financial Officer) sold 2,000 shares at $109.61 per share price.Also, On Apr 26, 2016, Louise Francesconi (director) sold 4,985 shares at $108.93 per share price.On Apr 25, 2016, William E Jr Berry (VP, Corporate Controller) sold 3,339 shares at $109.23 per share price.
Shares of Stryker Corporation (SYK) ended Wednesday, May 4, 2016 session in red amid volatile trading. The shares closed down -0.58 points or -0.53% at $108.59 with 9,36,723 shares getting traded. Post opening the session at $108.61, the shares hit an intraday low of $108.01 and an intraday high of $109.14 and the price vacillated in this range throughout the day. The company has a market cap of $40,611 M and the number of outstanding shares has been calculated to be 37,39,81,100 shares. The 52-week high of Stryker Corporation is $113.85 and the 52-week low is $86.68.
Company has been under the radar of several Street Analysts.Stryker Corporation is Upgraded by Sterne Agee CRT to Buy. Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on Apr 27, 2016.Stryker Corporation is Reiterated by RBC Capital Mkts to Outperform and the brokerage firm has raised the Price Target to $ 120 from a previous price target of $108 .The Rating was issued on Apr 26, 2016.Stryker Corporation is Downgraded by Robert W. Baird to Neutral and the brokerage firm has raised the Price Target to $ 116 from a previous price target of $111 .Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on Apr 13, 2016.Stryker Corporation is Resumed by Barclays to Underweight and the brokerage firm has set the Price Target at $107. The Rating was issued on Apr 11, 2016.Stryker Corporation is Initiated by Nomura to Neutral. The Rating was issued on Mar 17, 2016.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.